{"id":2682,"date":"2020-09-03T21:31:00","date_gmt":"2020-09-03T21:31:00","guid":{"rendered":"https:\/\/www.cubasupport.ie\/latest\/?p=2682"},"modified":"2020-09-04T22:46:28","modified_gmt":"2020-09-04T22:46:28","slug":"how-did-cubas-covid-19-candidate-vaccine-come-to-be-named-soberana","status":"publish","type":"post","link":"https:\/\/www.cubasupport.ie\/latest\/how-did-cubas-covid-19-candidate-vaccine-come-to-be-named-soberana\/","title":{"rendered":"How did Cuba\u2019s COVID-19 candidate vaccine come to be named Soberana?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">A name identifies, makes unique, and enamors\u2026 It is a calling card and can convey confidence and pride, which is exactly what occurred this month of August, when the people of Cuba heard the long-awaited news that our scientists had come up with an idea, an idea they turned into a vial of vaccine in just three months\u2019 time, as one researcher said.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Author:&nbsp;<a href=\"http:\/\/en.granma.cu\/archivo?a=1955\">Yisell Rodr\u00edguez Mil\u00e1n<\/a><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"460\" height=\"340\" src=\"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana.jpeg?resize=460%2C340&#038;ssl=1\" alt=\"\" class=\"wp-image-2683\" srcset=\"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana.jpeg?w=460&amp;ssl=1 460w, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana.jpeg?resize=300%2C222&amp;ssl=1 300w\" sizes=\"auto, (max-width: 460px) 100vw, 460px\" \/><figcaption>Soberana is the name given Cuba\u2019s first candidate vaccine, which began clinical trials August 24, to demonstrate its effectiveness against the virus SARS-COV-2, which causes COVID-19.<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">A name identifies, makes unique, and enamors\u2026 It is a calling card and can convey confidence and pride, which is exactly what occurred this month of August, when the people of Cuba heard the long-awaited news that our scientists had come up with an idea, an idea they turned into a vial of vaccine in just three months\u2019 time, as one researcher said.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Soberana (Sovereign) was the name given the candidate vaccine that, August 24, began its first clinical trials to demonstrate effectiveness against the SARS-COV-2 virus that causes COVID-19, an illness that has taken thousands of lives and cast the world into a deep economic crisis affecting, above all, those who have historically been the world\u2019s most vulnerable.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">IT ALL BEGAN\u2026<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">According to Naturaleza Secreta, that has carefully documented details of the propagation of COVID-19 in Cuba and the battle against it, the name Soberana appeared for the first time, written by hand, at the bottom of a piece of paper along with the information needed for clinical trials of the first candidate vaccine against the virus.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">On this same sheet, other possible names had been noted as well, none of which appeared to work, although a designation had to be chosen, as an unavoidable requirement to register the clinical trials, thus obliging experts at the Finlay Vaccine Institute, the Molecular Biology Institute and the University of Havana &#8211; responsible for the bulk of the research process that produced the vaccine \u2013 to make up their minds.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It was Dr. Meiby de la Caridad Rodr\u00edguez Gonz\u00e1lez, director of research at the Finlay who had the task of filling out the forms for the registration, who proposed calling the clinical trials project for the Cuban candidate vaccine Soberana 01.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">She was at home, working late along with the rest of the team, hoping to have everything ready by August 13, to honor, on the anniversary of his birth, the man who inspired Cuba\u2019s scientific development and especially the biotechnology sector: Fidel.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Upon hearing the proposal, members of the team who developed the vaccine, led by the institute\u2019s director, Vicente V\u00e9rez Bencomo, immediately looked at each other and nodded. Soberana was accepted without discussion, without hesitation, with the \u201c01\u201d designation for the project as the first clinical trial of a candidate vaccine, according to Naturaleza Secreta.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The scientists have since said that underlying the selection of the name was the comment made by President Miguel D\u00edaz-Canel Berm\u00fadez, this past May 19, on the necessity of developing a Cuban vaccine for COVID-19, regardless of what other countries might do, to give us sovereignty.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Referring to a possible Cuban candidate vaccine, the President said at that time, \u201cThe development of a vaccine would complete the feat we have accomplished.\u201d He emphasized that adding a vaccine to the achievements of Cuban science, as soon as possible, would be \u201can important contribution from all points of view.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The rest is history, Naturaleza Secreta notes in its article. The news that Cuba has its own vaccine entering clinical trials has gone viral on the Internet and the country\u2019s citizens have named it, on their own\u2026 sovereignly.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cIt was the people who really selected the name Soberana, because of the pride it gives us, and this will be the commercial name of the vaccine used in the country,\u201d stated Vicente V\u00e9rez, this past August 20, on the Cuban television program, Mesa Redonda.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This name is now that of the vaccine, not only of the clinical trials project. Nor will it be the name of the second candidate vaccine, already in the works,<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Naturaleza Secreta concludes, reporting how difficult it was to get this story, since, \u201cAmong the team members who created the Cuban vaccine against COVID-19, no one wants to take any individual credit,\u201d insisting that this project, with all its merits and beautiful, universally accepted name, is a collective work.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Source :<a href=\"http:\/\/en.granma.cu\/cuba\/2020-09-03\/how-did-cubas-covid-19-candidate-vaccine-come-to-be-named-soberana\" data-type=\"URL\" data-id=\"http:\/\/en.granma.cu\/cuba\/2020-09-03\/how-did-cubas-covid-19-candidate-vaccine-come-to-be-named-soberana\">Granma<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A name identifies, makes unique, and enamors\u2026 It is a calling card and can convey confidence and pride, which is exactly what occurred this month<a class=\"moretag\" href=\"https:\/\/www.cubasupport.ie\/latest\/how-did-cubas-covid-19-candidate-vaccine-come-to-be-named-soberana\/\"> [&#8230;]<\/a><\/p>\n","protected":false},"author":101011,"featured_media":2683,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[36,8],"tags":[],"class_list":["post-2682","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-covid-19","category-cuba"],"jetpack_publicize_connections":[],"jetpack-related-posts":[{"id":2700,"url":"https:\/\/www.cubasupport.ie\/latest\/media-silence-about-cubas-contributions-against-covid-19-denounced\/","url_meta":{"origin":2682,"position":0},"title":"Media silence about Cuba&#8217;s contributions against Covid-19 denounced","author":"Editorial Team","date":"September 7, 2020","format":false,"excerpt":"Foreign Minister Bruno Rodriguez on Friday denounced the international media silence about Cuba's scientific contributions to the fight against the Covid-19 pandemic.On his Twitter account, the head of Cuban diplomacy noted that, even if men and women of science in the country 'share their achievements with the world, they show\u2026","rel":"","context":"In &quot;Cuba&quot;","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Bruno-twiter.jpg?fit=748%2C498&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Bruno-twiter.jpg?fit=748%2C498&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Bruno-twiter.jpg?fit=748%2C498&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Bruno-twiter.jpg?fit=748%2C498&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":4747,"url":"https:\/\/www.cubasupport.ie\/latest\/cubas-soberana-02-covid-19-vaccine-to-reach-95-efficiency\/","url_meta":{"origin":2682,"position":1},"title":"Cuba&#8217;s Soberana 02 COVID-19 Vaccine To Reach 95% Efficiency","author":"Editorial Team","date":"June 27, 2021","format":false,"excerpt":"The\u00a0clinical trial's\u00a0preliminary results show a significant increase in the immune responses of patients between the second and third doses. On Thursday, Cuba\u2019s Finlay Vaccine Institute announced that its Soberana 02 COVID-19 vaccine is most likely to reach\u00a0up to\u00a095 percent efficiency in third phase of clinical trials. FVI scientist Maria Toledo\u2026","rel":"","context":"In &quot;Featured&quot;","block_context":{"text":"Featured","link":"https:\/\/www.cubasupport.ie\/latest\/category\/news\/featured\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3049,"url":"https:\/\/www.cubasupport.ie\/latest\/cuban-vaccine-soberana-02-to-start-phase-clinical-trials\/","url_meta":{"origin":2682,"position":2},"title":"Cuban Vaccine Soberana 02 To Start Phase Clinical Trials","author":"Editorial Team","date":"October 30, 2020","format":false,"excerpt":"Soberana 02 is the second Cuban COVID-19 vaccine candidate to begin clinical trials after being approved by Cuba's\u00a0medical regulatory authorities. The Cuban vaccine candidate against COVID-19, Soberana 02, will start Phase I clinical trials after receiving the approval of the Center for State Control of Drugs, Equipment, and Medical Devices\u2026","rel":"","context":"In &quot;Featured&quot;","block_context":{"text":"Featured","link":"https:\/\/www.cubasupport.ie\/latest\/category\/news\/featured\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?fit=800%2C513&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?fit=800%2C513&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?fit=800%2C513&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?fit=800%2C513&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":5290,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-accelerates-vaccine-drive\/","url_meta":{"origin":2682,"position":3},"title":"Cuba Accelerates Vaccine Drive","author":"Editorial Team","date":"October 5, 2021","format":false,"excerpt":"BY\u00a0HELEN YAFFE \u201cCuba has developed different RBD-based public vaccines, the most administered worldwide (protein-based), and among them the only SARS-CoV-2 conjugate-vaccine (RBD-TT), designed especially for children.\u201d\u2013 Tweet by Fabrizio Chiodo, Italian scientist working with Cuba\u2019s Finlay Institute.[1] Following clinical trials carried out over the summer, on 3 September 2021, Cuba\u2019s\u2026","rel":"","context":"In &quot;Featured&quot;","block_context":{"text":"Featured","link":"https:\/\/www.cubasupport.ie\/latest\/category\/news\/featured\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/abdela.jpeg?fit=960%2C540&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/abdela.jpeg?fit=960%2C540&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/abdela.jpeg?fit=960%2C540&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/abdela.jpeg?fit=960%2C540&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3578,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-will-vaccinate-its-entire-population-against-covid-19-in-2021\/","url_meta":{"origin":2682,"position":4},"title":"Cuba will vaccinate its entire population against COVID-19 in 2021","author":"Editorial Team","date":"January 27, 2021","format":false,"excerpt":"The BioCubaFarma enterprise group is adjusting capacity to make possible the administration of Soberana 02 to more than 150,000 persons, while a new clinical trial with children has been launched, as more steps are taken along the path to vaccinating the entire population. Photo: BioCubaFarma Dr. Eduardo Mart\u00ednez, president of\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027859.jpg?fit=700%2C406&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027859.jpg?fit=700%2C406&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027859.jpg?fit=700%2C406&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027859.jpg?fit=700%2C406&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2632,"url":"https:\/\/www.cubasupport.ie\/latest\/soberana-is-cubas-the-first-candidate-vaccine-against-covid-19-in-latin-america-and-the-caribbean\/","url_meta":{"origin":2682,"position":5},"title":"Soberana is Cuba\u2019s, the first candidate vaccine against COVID-19 in Latin America and the Caribbean","author":"Editorial Team","date":"August 27, 2020","format":false,"excerpt":"A vaccine that exemplifies the development of Cuban science; that places us on the level of economically advanced countries; that honors Comandante en Jefe Fidel Castro Ruz, the principal architect of the country\u2019s biotechnology sector. This is what Soberana is, the first Cuban candidate vaccine against COVID-19 authorized for testing\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027363.jpg?fit=700%2C452&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027363.jpg?fit=700%2C452&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027363.jpg?fit=700%2C452&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027363.jpg?fit=700%2C452&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p3xdTY-Hg","jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana.jpeg?fit=460%2C340&ssl=1","_links":{"self":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/2682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/users\/101011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/comments?post=2682"}],"version-history":[{"count":0,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/2682\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media\/2683"}],"wp:attachment":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media?parent=2682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/categories?post=2682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/tags?post=2682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}